相似文献
1
Thinking about Enhanced Permeability and Retention Effect (EPR).
J Pers Med. 2022 Jul 30;12(8):1259. doi: 10.3390/jpm12081259.
2
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Theranostics. 2020 Jun 25;10(17):7921-7924. doi: 10.7150/thno.49577. eCollection 2020.
3
Advocation and advancements of EPR effect theory in drug delivery science: A commentary.
J Control Release. 2022 Jun;346:355-357. doi: 10.1016/j.jconrel.2022.04.031. Epub 2022 Apr 30.
4
The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application.
J Pers Med. 2021 Aug 6;11(8):771. doi: 10.3390/jpm11080771.
5
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation.
J Control Release. 2022 May;345:512-536. doi: 10.1016/j.jconrel.2022.03.043. Epub 2022 Mar 23.
6
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.
Cancer Res. 2013 Apr 15;73(8):2412-7. doi: 10.1158/0008-5472.CAN-12-4561. Epub 2013 Feb 19.
7
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
J Control Release. 2016 Dec 28;244(Pt A):108-121. doi: 10.1016/j.jconrel.2016.11.015. Epub 2016 Nov 18.
8
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.
Theranostics. 2020 Jan 1;10(2):567-584. doi: 10.7150/thno.36777. eCollection 2020.
9
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
J Drug Target. 2007 Aug-Sep;15(7-8):457-64. doi: 10.1080/10611860701539584.
10
The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects.
J Pers Med. 2021 Mar 22;11(3):229. doi: 10.3390/jpm11030229.
引用本文的文献
1
Remote Co-Loading of Doxorubicin and Hydralazine into PEGylated Liposomes: In Vitro Anti-Proliferative Effect Against Breast Cancer.
Molecules. 2025 Mar 31;30(7):1549. doi: 10.3390/molecules30071549.
2
Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems.
Pharmaceutics. 2025 Feb 24;17(3):296. doi: 10.3390/pharmaceutics17030296.
3
Red Blood Cell Membrane Vesicles for siRNA Delivery: A Biocompatible Carrier With Passive Tumor Targeting and Prolonged Plasma Residency.
Int J Nanomedicine. 2025 Mar 15;20:3269-3301. doi: 10.2147/IJN.S504644. eCollection 2025.
4
Introducing carbon quantum dot-Capivasertib drug carrier complex for enhanced treatment of breast cancer.
PLoS One. 2025 Mar 11;20(3):e0319206. doi: 10.1371/journal.pone.0319206. eCollection 2025.
5
SN-38-indoximod conjugate: carrier free nano-prodrug for cancer therapy.
Ther Deliv. 2025 Mar;16(3):217-226. doi: 10.1080/20415990.2025.2458449. Epub 2025 Jan 31.
6
Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges.
Pharmaceutics. 2025 Jan 7;17(1):70. doi: 10.3390/pharmaceutics17010070.
7
Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics.
Nanoscale Adv. 2024 Jan 2;6(8):2026-2037. doi: 10.1039/d3na00953j. eCollection 2024 Apr 16.
8
Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Int J Mol Sci. 2024 Jan 4;25(1):664. doi: 10.3390/ijms25010664.
9
Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity.
Pharmaceutics. 2023 Sep 30;15(10):2406. doi: 10.3390/pharmaceutics15102406.
10
Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies.
Cancers (Basel). 2023 Aug 14;15(16):4091. doi: 10.3390/cancers15164091.
本文引用的文献
1
The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application.
J Pers Med. 2021 Aug 6;11(8):771. doi: 10.3390/jpm11080771.
2
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Theranostics. 2020 Jun 25;10(17):7921-7924. doi: 10.7150/thno.49577. eCollection 2020.
3
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
J Control Release. 2016 Dec 28;244(Pt A):108-121. doi: 10.1016/j.jconrel.2016.11.015. Epub 2016 Nov 18.
4
Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Nat Biotechnol. 2015 Sep;33(9):941-51. doi: 10.1038/nbt.3330.
5
EPR: Evidence and fallacy.
J Control Release. 2014 Sep 28;190:451-64. doi: 10.1016/j.jconrel.2014.03.057. Epub 2014 Apr 30.
6
The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.
Cancer Sci. 2013 Jul;104(7):779-89. doi: 10.1111/cas.12152. Epub 2013 Apr 22.
7
Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.
ACS Nano. 2013 Jan 22;7(1):717-24. doi: 10.1021/nn305011p. Epub 2012 Dec 18.
8
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
Adv Drug Deliv Rev. 2013 Jan;65(1):71-9. doi: 10.1016/j.addr.2012.10.002. Epub 2012 Oct 23.
9
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.
Nat Nanotechnol. 2012 Apr 8;7(6):383-8. doi: 10.1038/nnano.2012.45.
10
Tumor delivery of macromolecular drugs based on the EPR effect.
Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5. doi: 10.1016/j.addr.2010.03.011. Epub 2010 Mar 18.
Zotero 插件